SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-24-061913
Filing Date
2024-05-15
Accepted
2024-05-15 16:07:41
Documents
18
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2414578d2_10qa.htm   iXBRL 10-Q/A 48339
2 EXHIBIT 31.1 tm2414578d2_ex31-1.htm EX-31.1 9619
3 EXHIBIT 31.2 tm2414578d2_ex31-2.htm EX-31.2 9721
4 EXHIBIT 32.1 tm2414578d2_ex32-1.htm EX-32.1 4087
5 EXHIBIT 32.2 tm2414578d2_ex32-2.htm EX-32.2 4243
  Complete submission text file 0001104659-24-061913.txt   318391

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zura-20240331.xsd EX-101.SCH 3505
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240331_def.xml EX-101.DEF 26538
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240331_lab.xml EX-101.LAB 36483
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240331_pre.xml EX-101.PRE 25162
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2414578d2_10qa_htm.xml XML 6879
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40598 | Film No.: 24950546
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)